A dose-ranging study of the oral direct thrombin inhibitor, ximelagatran, and its subcutaneous form, melagatran, compared with dalteparin in the prophylaxis of thromboembolism after hip or knee replacement: METHRO I. MElagatran for THRombin inhibiti (Q50143647)
Jump to navigation
Jump to search
scientific article published in February 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A dose-ranging study of the oral direct thrombin inhibitor, ximelagatran, and its subcutaneous form, melagatran, compared with dalteparin in the prophylaxis of thromboembolism after hip or knee replacement: METHRO I. MElagatran for THRombin inhibiti |
scientific article published in February 2002 |
Statements
1 reference
A dose-ranging study of the oral direct thrombin inhibitor, ximelagatran, and its subcutaneous form, melagatran, compared with dalteparin in the prophylaxis of thromboembolism after hip or knee replacement: METHRO I. MElagatran for THRombin inhibiti (English)
1 reference
Bengt I Eriksson
1 reference
Ann-Christin Arfwidsson
1 reference
Lars Frison
1 reference
Ulf G Eriksson
1 reference
Anders Bylock
1 reference
Peter Kälebo
1 reference
Gunnar Fager
1 reference
David Gustafsson
1 reference
1 February 2002
1 reference
87
1 reference
2
1 reference
231-237
1 reference